Plasma levels of sCD163 and sCD14 independently predict mortality during HIV infection, have been associated with the development of HIV-associated comorbidities, and have been linked to higher myeloid cell activation, especially by microbial translocation (30–34). This evidence concerns the gene CD163 and HIV infectious disease.